Abstract:Introduction: Ischemic stroke results in activation of microglia, which may polarize towards a pro-inflammatory (M1) phenotype and/or an anti-inflammatory (M2) phenotype. Enhancer of zeste homolog (EZH) 2 is a histone-lysine N-methyltransferase enzyme, a key modulator of microglia polarization. We here investigated whether microglial-specific deletion of EZH2 leads to a beneficial protective effect in stroke and microglial over-expressing microglial EZH2 exacerbates stroke outcome in vivo . Methods: Aged male mice were subjected to 60-minutes middle cerebral artery stroke. Tamoxifen administration was started 30 days prior to stroke to induce genetic deletion of microglial EZH2 in CX3CR1-creER/EZH2-floxed mice. EZH2 floxed mice were used as controls. Microglial EZH2 over-expressing was performed using lentiviral vectors. Mice were sacrificed for immunohistochemistry and crystal violet staining (brain infarct assay) after behavior tests at 3 days after stroke. Results: The expression of microglial EZH2 was significantly abrogated with tamoxifen injection in KO mice compared to the control floxed mice (144±15.43 vs. 50.65±4.99 cells/mm 2 , P<0.01, N=5/each group). EZH2 deletion reduced brain infarct volume (29.27±2.23% vs. 6.07±0.88%, P<0.001, N=7/each group) and improved functional outcome assayed by adhesive removal test (59±13.1 seconds, N=7 in control vs. 26.28±4.1 seconds, N=12 in KO, P<0.01). Mechanistically, microglial EZH2 deletion led to a decrease in expression of M1 marker iNOS (170±14.78 vs. 76.65±11.38 cells/mm 2 , P<0.05, N=4/each group), an increase in M2 marker Arg1 (96.64±11.48 vs. 203.3±22.02 cells/mm 2 , P<0.05, N=4/each group) co-stained in microglia (Iba1). We additionally found over-expressing EZH2 in microglial cells exacerbated stroke outcome including performance in adhesive tape removal and hang-wire tests 3 days after stroke. We observed decreased Arg1 and increased iNOS in stroke mice with over-expression of EZH2 (n= 5/6, p=<0.05). Conclusions: Genetic deletion of EZH2 in microglia improved stroke outcome in aged while overexpression of EZH2 exacerbated stroke outcome. The effect of protective effect of EZH2 inhibition may be due to limiting microglial M1 polarization and enhancing M2 polarization.

Severe Hypertriglyceridemia Does Not Protect from Ischemic Brain Injury in Gene-Modified Hypertriglyceridemic Mice

Apolipoprotein E deficiency exacerbates blood-brain barrier disruption and hyperglycemia-associated hemorrhagic transformation after ischemic stroke

Role of protease activated receptor-1 in thrombin preconditioning against thrombin-induced brain injury in mice

Abstract 398: Inhibition of Tissue Factor Reduces Thrombosis and Inflammation Without Increased Bleeding in a Mouse Model of Ischemic Stroke

Hyperglycemia Abolished Drp-1-mediated Mitophagy at the Early Stage of Cerebral Ischemia.

Analysis of the Hemorheological Abnormalities in Mice with Severe Hypertriglyceridemia

Hypertriglyceridemia Is Associated with Reduced Leukoaraiosis Severity in Patients with a Small Vessel Stroke

Severe hypertriglyceridemia caused by Gpihbp1 deficiency facilitates vascular remodeling through increasing endothelial activation and oxidative stress

High Triglyceride Glucose Index Is Associated with Poor Outcomes in Ischemic Stroke Patients after Reperfusion Therapy

Reduced Early Hypoxic/ischemic Brain Damage is Associated with Increased GLT-1 Levels in Mice Expressing Mutant (P301L) Human Tau

Ischemic Myocardial Protection in Transgenic Mice with Cardiac Α1a‐adrenergic Receptor Overexpression

Association of triglyceride glucose index with stroke: from two large cohort studies and Mendelian randomization analysis

Protection Against Experimental Stroke by Ganglioside GM1 is Associated with the Inhibition of Autophagy

Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke?

Abstract P747: Gpr68 Play a Protective Role in Ischemic Stroke in Mice

Inactivation of mouse transmembrane prolyl 4-hydroxylase increases blood brain barrier permeability and ischemia-induced cerebral neuroinflammation

Total cholesterol affects the outcome in anterior cerebral artery-occluded acute ischemic stroke patients treated with thrombolysis

Aggravated Restenosis and Atherogenesis in ApoCIII Transgenic Mice but Lack of Protection in ApoCIII Knockouts: the Effect of Authentic Triglyceride-Rich Lipoproteins with and Without ApoCIII.

Modulating monocyte-derived macrophage polarization in cerebral ischemic injury with hyperglycemia

Abstract 16: Inhibiting Ezh2 Is Neuroprotective After Stroke In Aged Mice

Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke